Maynard Um
-
-
-
-
-
-
-
Tempus AI launches OneOme pharmacogenomics testing nationally
-
-
-
-
-
-
-
Tempus AI partners with Angiosarcoma Awareness on rare cancer data
-
-
-
-
-
-
-
Tempus expands AI platform to six new cancer types for clinical insights
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Raised to $68 at TD Cowen
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Lowered to $60 at Stifel, Firm Highlights 'Solid' Outlook
-
-
-
-
-
-
-
Tempus launches AI-powered biomarker prediction tool Paige Predict
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Raised to $105 at BTIG
-
431,647 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

